A study by Selcukbirik et al. (2003) [45] suggested a significant correlation between KRAS mutations and high initial CEA level, while Zhao et al. (2021) [46] claimed no differences in CEA levels between wild-type and mutant KRAS in CRC. Here, CEACAM5 is linked to colorectal carcinoma.